LANGUAGE

Development of CAR-T cell

based on a newly identified tumor antigen

MJ Cellbio – Beyond New Horizon

. . .

Development of CAR-T cell

based on a newly identified tumor antigen

MJ Cellbio – Beyond New Horizon

. . .

Development of CAR-T cell

based on a newly identified tumor antigen

MJ Cellbio – Beyond New Horizon

. . .

MJCELLBIO

MJCellBio focuses on development of CAR-T cell targeting the new tumor antigen that has not been attempted before clinically. In addition, MJCellBio is working on development of ‘Universal (allogeneic) CAR-T cell’ overcoming the disadvantages of ‘autologous CAR-T cell’.

COMPANY

MJCellBio will lead us to the future
where we don’t have to fear cancers

CAR-T

Ligand based next generation CAR-T
to overcome heterogeneity of target tumors

PIPELINE

Development of NK cell therapy active
even in tumor microenvironment

CAR-T Treatment

* LV: Lentivirus gene delivery system

CAR-T Cell Mediated Cytotoxicity

Business plan for CAR-T cell therapy product

LATEST NEWS

공동연구계약 발표 미팅(21.02.02)

공동연구계약 발표 미팅(21.02.02)

2021-02-05

건국대학교 산학협력단( 연구책임자 조쌍구)과 유도만능줄기세포 유래 면역세포 유전자 재조합을 통한 암 면역질환 치료기술에 대한 공동연구계약 결과발표 미팅_21.02.02